遊族網絡(002174.SZ):預計後續將觸發“遊族轉債”轉股價修正條件
格隆匯2月14日丨遊族網絡(002174.SZ)公佈,截至2023年2月14日,公司股票已有連續多個交易日的收盤價持續低於當期轉股價格16.97元/股的90%,即15.27元/股的情形,預計後續將觸發“遊族轉債”轉股價格修正條件。
根據《深圳證券交易所上市公司自律監管指引第15號——可轉換公司債券》相關規定,“觸發轉股價格修正條件當日,上市公司應當召開董事會審議決定是否修正轉股價格,在次一交易日開市前披露修正或者不修正可轉債轉股價格的提示性公吿,並按照募集説明書或者重組報吿書的約定及時履行後續審議程序和信息披露義務。上市公司未按本款規定履行審議程序及信息披露義務的,視為本次不修正轉股價格。”
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.